- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-01-0009171

About Crop Life Science Limited
Data last updated:
Crop Life Science Limited is a public limited company based in Vadodara, Gujarat, India. It operates in the fertilizers and soil enhancers segment of the agriculture sector. It was incorporated on 24 May 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24124GJ2006PLC048297. Its GSTIN is 24AACCC8249E1ZT (Gujarat). The company holds 14 GST registrations, of which 8 are active. It is a listed company as per MCA records. Its shares are listed on NSE: CLSL.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹17.14 Cr. It is led by directors including Rajeshkumar Vrajlal Lunagariya (Managing Director) and Ashvinkumar Ravji Lunagaria (Whole-Time Director).
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 6th Floor Abs Tower, Near Chakli Circle O.P. Road Vadodara, Gujarat, India – 390007.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹207.17 Cr, a growth of 3.3% compared to the previous year. For the same year it recorded a net profit of ₹6.54 Cr (net margin 3.2%) and EBITDA of ₹17.77 Cr (EBITDA margin 8.6%). The net worth stands at ₹84.25 Cr (up 8.8% YoY). Total assets are valued at ₹145.66 Cr (up 14.9% YoY).
The company has about 182 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Crop Life Science. As per MCA filings, the company has open charges of ₹72.6 Cr and satisfied charges of ₹10.59 Cr on record. Court records list 641 cases involving the company, including 597 filed by the company and 44 filed against it; 145 cases are pending. The company has 16 deals on record (13 secondary share transfers, 2 funding rounds, 1 ipo), with disclosed funding of ₹7.08 Cr; the latest was in August 2023. Its 5 peer companies in the Agriculture industry (Fertilizers, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Positive Chemicals Private Limited with revenue of ₹203.14 Cr. The company has 25 MSME Form 1 returns on record between 2017 and 2024, listing 6,434 overdue payments to 163 micro and small suppliers.
Crop Life Science Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0009171). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website croplifescience.com.
Company details
CIN history
Crop Life Science has one previous CIN (Corporate Identification Number): U24124GJ2006PLC048297. The current CIN is L24124GJ2006PLC048297, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24124GJ2006PLC048297 | Current |
| U24124GJ2006PLC048297 | Previous |
Recognitions & Rankings of Crop Life Science
Contact details
Crop Life Science Limited's registered office is in Vadodara, Gujarat. Its website is croplifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address6th Floor Abs Tower, Near Chakli Circle O.P. Road Vadodara, Gujarat, India – 390007
- IndustryAgriculture, Fertilizers & Soil Enhancers, Crop Protection
To see the full contact details of Crop Life Science Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Crop Life Science operates one associated brand: Crop Life Science. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Insecticides, fungicides, herbicides, and plant health products are manufactured. | croplifescience.com |
Business activity
The main business activity of Crop Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Crop Life Science Limited, buy the company report.
Financials of Crop Life Science Limited
FY 2025-26 filings availableCrop Life Science Limited reported revenue of ₹207.17 Cr (up 3.3% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 207 | 201 | 199 | 131 |
| Revenue growth | +3.3% | +1.0% | +51.3% | - |
| EBITDA | 17.77 | 16.34 | 12.62 | 11.79 |
| EBITDA margin | +8.6% | +8.2% | +6.4% | +9.0% |
| Profit before tax | 9.22 | 7.78 | 8.11 | 5.61 |
| Net profit | 6.54 | 5.89 | 5.67 | 4.08 |
| Net profit margin | +3.2% | +2.9% | +2.9% | +3.1% |
| EPS (₹) | 3.87 | 3.44 | 3.51 | 3.39 |
| Balance sheet | ||||
| Total assets | 146 | 127 | 112 | 68.03 |
| Net worth | 84.25 | 77.45 | 71.73 | 40.55 |
| Total debt | 56.57 | 44.31 | 35.40 | 26.99 |
| Cash & bank | 3.48 | 0.95 | 2.39 | 0.38 |
| Net working capital | 115 | 88.19 | 73.46 | 52.07 |
| Cash flow | ||||
| Cash from operations | (7.63) | (1.50) | (8.33) | 2.27 |
| Cash from investing | 1.58 | (4.11) | (3.42) | (4.48) |
| Cash from financing | (8.83) | (6.72) | 13.43 | 0.52 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 207 | 201 | 199 | 131 | 102 | 119 | 135 |
| Revenue growth | +3.3% | +1.0% | +51.3% | +28.6% | -14.2% | -12.0% | - |
| EBITDA | 16.97 | 15.89 | 12.63 | 11.78 | 7.71 | 8.73 | 8.26 |
| EBITDA margin | +8.2% | +7.9% | +6.4% | +9.0% | +7.6% | +7.3% | +6.1% |
| Profit before tax | 9.89 | 9.00 | 8.14 | 5.60 | 3.77 | 4.91 | 4.58 |
| Net profit | 6.89 | 6.62 | 5.69 | 4.07 | 2.78 | 3.64 | 3.22 |
| Net profit margin | +3.3% | +3.3% | +2.9% | +3.1% | +2.7% | +3.1% | +2.4% |
| EPS (₹) | 4.08 | 3.86 | 3.53 | 3.39 | 2.35 | 3.09 | 2.69 |
| Balance sheet | |||||||
| Total assets | 143 | 124 | 106 | 68.03 | 58.75 | 52.53 | 46.36 |
| Net worth | 85.35 | 78.20 | 71.74 | 40.55 | 36.02 | 33.15 | 29.70 |
| Total debt | 56.57 | 44.31 | 33.89 | 26.99 | 21.52 | 18.24 | 16.03 |
| Cash & bank | 2.93 | 0.73 | 0.58 | 0.38 | 2.07 | 3.09 | 2.31 |
| Net working capital | 113 | 87.40 | 71.17 | 52.07 | 45.60 | 39.46 | 34.37 |
| Cash flow | |||||||
| Cash from operations | (7.91) | (1.70) | (8.28) | 2.27 | (0.15) | 3.50 | 2.51 |
| Cash from investing | 1.53 | (3.83) | (15.89) | (4.48) | (1.99) | (2.15) | (0.74) |
| Cash from financing | (8.83) | (5.20) | 24.36 | 0.52 | 1.11 | (0.57) | (2.52) |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Revenue | 207 | 201 | 199 | 131 |
| Revenue growth | +3.3% | +1.0% | +51.3% | - |
| Other income | 1.83 | 1.02 | 2.11 | 0.80 |
| Total expenses | 189 | 184 | 186 | 119 |
| Employee cost | 13.86 | 12.79 | 11.26 | 11.29 |
| EBITDA | 17.77 | 16.34 | 12.62 | 11.79 |
| EBITDA margin | +8.6% | +8.2% | +6.4% | +9.0% |
| Depreciation | 4.94 | 4.83 | 3.23 | 3.71 |
| Interest | 5.44 | 4.75 | 3.39 | 3.27 |
| Profit before tax | 9.22 | 7.78 | 8.11 | 5.61 |
| Tax | 2.74 | 2.19 | 2.09 | 1.53 |
| Net profit | 6.54 | 5.89 | 5.67 | 4.08 |
| Net profit margin | +3.2% | +2.9% | +2.9% | +3.1% |
| EPS (₹) | 3.87 | 3.44 | 3.51 | 3.39 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Equity & liabilities | ||||
| Share capital | 17.14 | 17.14 | 17.14 | 12.00 |
| Reserves & surplus | 67.11 | 60.31 | 54.59 | 28.55 |
| Shareholders' funds (net worth) | 84.25 | 77.45 | 71.73 | 40.55 |
| Minority interest | 3.76 | 3.90 | 4.19 | 0.00 |
| Secured loans | 53.34 | 40.48 | 30.99 | 25.27 |
| Unsecured loans | 3.23 | 3.83 | 4.41 | 1.72 |
| Total debt | 56.57 | 44.31 | 35.40 | 26.99 |
| Total liabilities | 146 | 127 | 112 | 68.03 |
| Assets | ||||
| Gross block | 48.72 | 52.90 | 50.22 | 16.07 |
| Net block | 29.99 | 38.02 | 39.09 | 15.58 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.64 | 0.60 | 0.00 | 0.00 |
| Inventories | 70.56 | 48.89 | 39.82 | 26.19 |
| Sundry debtors | 74.14 | 69.29 | 77.26 | 32.56 |
| Cash & bank balances | 3.48 | 0.95 | 2.39 | 0.38 |
| Loans & advances | 28.48 | 23.05 | 20.51 | 26.43 |
| Total current assets | 177 | 142 | 140 | 85.56 |
| Total current liabilities | 61.72 | 53.99 | 66.52 | 33.49 |
| Net working capital | 115 | 88.19 | 73.46 | 52.07 |
| Total assets | 146 | 127 | 112 | 68.03 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Opening cash | (34.24) | (21.92) | 0.72 | 2.07 |
| Net cash from operating activities | (7.63) | (1.50) | (8.33) | 2.27 |
| Net cash from investing activities | 1.58 | (4.11) | (3.42) | (4.48) |
| Net cash from financing activities | (8.83) | (6.72) | 13.43 | 0.52 |
| Net change in cash | (14.89) | (12.32) | 1.67 | (1.69) |
| Closing cash | 3.48 | 0.95 | 2.39 | 0.38 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Growth | ||||
| Sales growth | +3.3% | +1.0% | +51.3% | - |
| EBITDA growth | +8.8% | +29.5% | +7.0% | - |
| PBT growth | +18.5% | -4.1% | +44.6% | +9997.0% |
| Net income growth | +11.0% | +3.9% | +39.0% | - |
| Revenue CAGR (3Y) | +16.4% | - | - | - |
| EBITDA CAGR (3Y) | +14.7% | - | - | - |
| Profitability & leverage | ||||
| Net income margin | +3.1% | +2.8% | +3.0% | +3.1% |
| Return on capital employed | +11.1% | +10.9% | +13.1% | +13.0% |
| Return on net worth | +8.0% | +7.5% | +10.7% | +10.0% |
| Debt / equity | 0.62 | 0.53 | 0.56 | 0.67 |
| Long-term debt / equity | 0.06 | 0.10 | 0.14 | 0.16 |
| Interest cover | 42.40 | 41.27 | 36.10 | 40.47 |
| Efficiency & per share | ||||
| Fixed asset turnover | 4.08 | 3.89 | 5.99 | 8.17 |
| Inventory turnover | 3.47 | 4.52 | 6.02 | 5.01 |
| Debtors turnover | 2.89 | 2.74 | 3.62 | 4.03 |
| EPS (₹) | 3.87 | 3.44 | 3.51 | 3.39 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 49.15 | 45.19 | 41.85 | 33.80 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 207 | 201 | 199 | 131 | 102 | 119 | 135 |
| Revenue growth | +3.3% | +1.0% | +51.3% | +28.6% | -14.2% | -12.0% | - |
| Other income | 1.77 | 0.98 | 2.10 | 0.80 | 0.38 | 0.57 | 0.18 |
| Total expenses | 190 | 185 | 186 | 119 | 94.30 | 110 | 127 |
| Employee cost | 13.86 | 12.67 | 11.26 | 11.29 | 10.88 | 11.06 | 9.84 |
| EBITDA | 16.97 | 15.89 | 12.63 | 11.78 | 7.71 | 8.73 | 8.26 |
| EBITDA margin | +8.2% | +7.9% | +6.4% | +9.0% | +7.6% | +7.3% | +6.1% |
| Depreciation | 3.41 | 3.12 | 3.21 | 3.71 | 2.25 | 2.52 | 1.75 |
| Interest | 5.44 | 4.75 | 3.38 | 3.27 | 2.07 | 1.87 | 2.11 |
| Profit before tax | 9.89 | 9.00 | 8.14 | 5.60 | 3.77 | 4.91 | 4.58 |
| Tax | 2.92 | 2.38 | 2.09 | 1.53 | 0.96 | 1.23 | 1.36 |
| Net profit | 6.89 | 6.62 | 5.69 | 4.07 | 2.78 | 3.64 | 3.22 |
| Net profit margin | +3.3% | +3.3% | +2.9% | +3.1% | +2.7% | +3.1% | +2.4% |
| EPS (₹) | 4.08 | 3.86 | 3.53 | 3.39 | 2.35 | 3.09 | 2.69 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 17.14 | 17.14 | 17.14 | 12.00 | 12.00 | 12.00 | 12.00 |
| Reserves & surplus | 68.21 | 61.06 | 54.60 | 28.55 | 24.02 | 21.15 | 17.70 |
| Shareholders' funds (net worth) | 85.35 | 78.20 | 71.74 | 40.55 | 36.02 | 33.15 | 29.70 |
| Secured loans | 53.34 | 40.48 | 29.62 | 21.50 | 17.68 | 17.11 | 13.41 |
| Unsecured loans | 3.23 | 3.83 | 4.27 | 5.49 | 3.84 | 1.13 | 2.62 |
| Total debt | 56.57 | 44.31 | 33.89 | 26.99 | 21.52 | 18.24 | 16.03 |
| Total liabilities | 143 | 124 | 106 | 68.03 | 58.75 | 52.53 | 46.36 |
| Assets | |||||||
| Gross block | 27.84 | 32.02 | 29.64 | 23.21 | 15.15 | 16.45 | 13.54 |
| Net block | 15.64 | 22.14 | 21.83 | 15.58 | 11.23 | 12.87 | 12.01 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 1.45 | 0.00 | 0.00 |
| Investments | 13.12 | 13.08 | 12.48 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 70.56 | 48.89 | 39.82 | 26.19 | 22.26 | 29.37 | 23.00 |
| Sundry debtors | 74.14 | 69.29 | 77.40 | 32.56 | 36.86 | 26.09 | 27.43 |
| Cash & bank balances | 2.93 | 0.73 | 0.58 | 0.38 | 2.07 | 3.09 | 2.31 |
| Loans & advances | 27.99 | 22.53 | 19.27 | 26.43 | 20.24 | 14.53 | 11.34 |
| Total current assets | 176 | 141 | 137 | 85.56 | 81.43 | 73.08 | 64.08 |
| Total current liabilities | 62.31 | 54.04 | 65.90 | 33.49 | 35.83 | 33.62 | 29.71 |
| Net working capital | 113 | 87.40 | 71.17 | 52.07 | 45.60 | 39.46 | 34.37 |
| Total assets | 143 | 124 | 106 | 68.03 | 58.75 | 52.53 | 46.36 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | (34.26) | (23.53) | 0.38 | 2.07 | 3.09 | 2.31 | 3.05 |
| Net cash from operating activities | (7.91) | (1.70) | (8.28) | 2.27 | (0.15) | 3.50 | 2.51 |
| Net cash from investing activities | 1.53 | (3.83) | (15.89) | (4.48) | (1.99) | (2.15) | (0.74) |
| Net cash from financing activities | (8.83) | (5.20) | 24.36 | 0.52 | 1.11 | (0.57) | (2.52) |
| Net change in cash | (15.22) | (10.73) | 0.20 | (1.69) | (1.02) | 0.78 | (0.75) |
| Closing cash | 2.93 | 0.73 | 0.58 | 0.38 | 2.07 | 3.09 | 2.31 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +3.3% | +1.0% | +51.3% | +28.6% | -14.2% | -12.0% | - |
| EBITDA growth | +6.8% | +25.8% | +7.2% | +52.8% | -11.7% | +5.7% | - |
| PBT growth | +9.9% | +10.6% | +45.4% | +48.5% | -23.2% | +7.2% | +9997.0% |
| Net income growth | +4.1% | +16.3% | +39.8% | +46.4% | -23.6% | +13.0% | - |
| Revenue CAGR (3Y) | +16.4% | +25.3% | +18.6% | -1.0% | - | - | - |
| EBITDA CAGR (3Y) | +12.9% | +27.3% | +13.1% | +12.6% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +3.4% | +3.3% | +3.1% | +3.1% | +2.8% | +3.1% | +2.4% |
| Return on capital employed | +11.5% | +12.0% | +13.2% | +14.0% | +10.5% | +13.7% | +14.5% |
| Return on net worth | +8.6% | +8.8% | +10.8% | +10.6% | +8.1% | +11.8% | +10.9% |
| Debt / equity | 0.62 | 0.52 | 0.54 | 0.63 | 0.57 | 0.55 | 0.54 |
| Long-term debt / equity | 0.06 | 0.09 | 0.13 | 0.11 | 0.08 | 0.09 | 0.07 |
| Interest cover | 40.12 | 37.20 | 35.88 | 40.52 | 37.91 | 30.11 | 32.41 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 6.92 | 6.51 | 7.52 | 6.84 | 6.46 | 7.93 | 9.98 |
| Inventory turnover | 3.47 | 4.52 | 6.02 | 5.42 | 3.95 | 4.54 | 5.88 |
| Debtors turnover | 2.89 | 2.73 | 3.61 | 3.78 | 3.24 | 4.44 | 4.93 |
| EPS (₹) | 4.08 | 3.86 | 3.53 | 3.39 | 2.35 | 3.09 | 2.69 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 49.79 | 45.63 | 41.86 | 33.80 | 30.02 | 27.62 | 24.75 |
To see the full year-wise statements and ratios of Crop Life Science Limited, buy the company report.
Board of directors of Crop Life Science Limited
Crop Life Science has 6 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeshkumar Vrajlal Lunagariya Also directs: Hetban Spechem Limited, CLSL Solutions Private Limited | Managing Director | 24 May 2006 | 20 Years 5 Months | Current |
| Ashvinkumar Ravji Lunagaria | Whole-Time Director | 24 May 2006 | 20 Years 5 Months | Current |
| Chunilal Samajubhai Virolia | Whole-Time Director | 10 Nov 2022 | 3 Years 11 Months | Current |
| Alpeshbhai Gordhanbhai Vaghasiya | Director | 30 Jul 2026 | 0 Years 3 Months | Current |
| Pareshbhai Bhagvanbhai Parsana | Director | 30 Jul 2026 | 0 Years 3 Months | Current |
| Sheetalben Rachit Shah | Director | 10 Apr 2026 | 0 Years 6 Months | Current |
Peer comparison
Crop Life Science Limited is compared with the 5 companies closest to it by revenue in the Agriculture industry (Fertilizers, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Crop Life Science Limitedthis company | ₹207.17 Cr (FY 2026) | ₹6.54 Cr | 3.2% | 3.3% | 182 | Vadodara, Gujarat, India |
| Positive Chemicals Private Limited | ₹203.14 Cr (FY 2025) | 11.0% | Rajkot, Gujarat, India | |||
| Blue Phosphate Limited | ₹202.39 Cr (FY 2025) | 16.0% | Roha, Maharashtra, India | |||
| Aimco Pesticides Limited | ₹198.86 Cr (FY 2025) | -5.0% | Lote Parshuram, Maharashtra, India | |||
| Abci Agrochem Private Limited | ₹192.34 Cr (FY 2025) | 11.0% | Bathinda, Punjab, India | |||
| Mahindra Summit Agriscience Limited | ₹191.92 Cr (FY 2025) | 40.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Crop Life Science Limited, buy the company report.
Auditor
Crop Life Science Limited is audited by SHAH & SHAH for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHAH & SHAH | FY 2024 | 131527W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 70.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 30.00%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 70.00% | 70.00% | 70.00% | 70.00% |
| Public | 30.00% | 30.00% | 30.00% | 30.00% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jun 2026 | 101333551 | Hdfc Bank Limited | ₹2.73 Cr | Open | |
| 05 Jun 2026 | 101303370 | Hdfc Bank Limited | ₹7.96 Cr | Open | |
| 23 Apr 2025 | 101085372 | Hdfc Bank Limited | ₹61 Lakh | Open | |
| 20 Apr 2024 | 100913729 | Hdfc Bank Limited | ₹25.9 Lakh | Open | |
| 08 Jan 2024 | 100909758 | Axis Bank Limited | ₹16.04 Cr | Open |
To see the full charge records of Crop Life Science Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Crop Life Science Limited has 16 deals on record (13 secondary share transfers, 2 funding rounds, 1 ipo), with disclosed funding of ₹7.08 Cr; the latest was in August 2023.
Deals on record (5 of 16)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2023 | IPO | ₹26.73 Cr | Investors: IPO Shareholders - Crop Life Science Limited, Nikunj Stock Brokers Limited , Assam Edible Oils Limited, an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 3 individuals |
| Sep 2017 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 3 individuals |
| May 2017 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
To see the full deal history of Crop Life Science Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Crop Life Science Limited has 641 court cases on record: 597 filed by Crop Life Science, 44 filed against it. 145 cases are pending and 496 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 625 | 35 | 145 |
| High courts | 16 | 9 | 0 |
Cases on record (5 of 641)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Criminal complaint | Filed by the company against Indoin Biolife Private Limited and 4 others | Pending |
| District court, Vadodara, Gujarat | Criminal complaint | Filed by the company against Aryan Crop Protection Private Limited and 2 others | Pending |
| High Court | Court case (CARBP) | Filed against the company by SML Limited | Disposed |
| District court, Vadodara, Gujarat | Court case (CR A) | Filed against the company by Shivashish Agro Agency Prop Karshan K Solanki | Pending |
| District court, Vadodara, Gujarat | Court case (CR A) | Filed against the company | Pending |
To see the full case history of Crop Life Science Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Crop Life Science Limited has 25 MSME Form 1 returns on record between 2017 and 2024, listing 6,434 overdue payments to 163 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 163)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Pragati Industries | |||
| GSP Crop Science Limited | |||
| Navkar Chemicals | |||
| an individual supplier |
To see the full MSME payment records of Crop Life Science Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Crop Life Science has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Hetban Spechem Limited | U24120GJ2014PLC079146 |
To see the full group structure of Crop Life Science Limited, buy the company report.
Employees & EPFO
Crop Life Science Limited has a workforce of 182 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Crop Life Science has 14 GST registrations: 8 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCC8249E1ZT | Gujarat | Active | 01 Jul 2017 |
| 24AACCC8249E2ZS | Gujarat | Active | 01 Mar 2025 |
| 09AACCC8249E1ZL | Uttar Pradesh | Active | 01 Jul 2017 |
| 10AACCC8249E1Z2 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Crop Life Science Limited, buy the company report.
Recent activity
Crop Life Science Limited has 31 board changes on record since 2006: 19 appointments and 12 cessations. The latest: Alpeshbhai Gordhanbhai Vaghasiya was appointed as Director on 30 Jul 2026.
43 earlier events are in the company report.
Frequently asked questions
Crop Life Science is an active public limited company based in Vadodara, Gujarat, India. The company works in fertilizers and soil enhancers, within the agriculture industry. It was incorporated on 24 May 2006 (20+ years old) and is registered under CIN L24124GJ2006PLC048297. Listed on NSE: CLSL.
Crop Life Science reported revenue of ₹207.17 Cr for FY 2025-26 (up 3.3% YoY) based on consolidated financials.
Crop Life Science has 6 current directors:
- Rajeshkumar Vrajlal Lunagariya - Managing Director
- Ashvinkumar Ravji Lunagaria - Whole-Time Director
- Chunilal Samajubhai Virolia - Whole-Time Director
- Alpeshbhai Gordhanbhai Vaghasiya - Director
- Pareshbhai Bhagvanbhai Parsana - Director
- Sheetalben Rachit Shah - Director
The latest financial statements of Crop Life Science on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Crop Life Science is 24AACCC8249E1ZT, registered in Gujarat. The company has 14 GST registrations in all, of which 8 are active and 6 are cancelled or inactive. Other active GSTINs include 24AACCC8249E2ZS (Gujarat), 09AACCC8249E1ZL (Uttar Pradesh), 10AACCC8249E1Z2 (Bihar).
The CIN (Corporate Identification Number) of Crop Life Science is L24124GJ2006PLC048297. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Crop Life Science is a listed company as per MCA records. Its shares are listed on NSE (symbol: CLSL).
Crop Life Science has 641 court cases on record: 597 filed by the company and 44 filed against it. 145 are pending. Most are in the district courts.
Crop Life Science was incorporated on 24 May 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Crop Life Science has 16 deals on record (13 secondary share transfers, 2 funding rounds, 1 ipo), with disclosed funding of ₹7.08 Cr; the latest was in August 2023.
The peers of Crop Life Science by revenue are Positive Chemicals Private Limited, Blue Phosphate Limited, Aimco Pesticides Limited, Abci Agrochem Private Limited, Mahindra Summit Agriscience Limited, all in the Agriculture industry (Fertilizers, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Alpeshbhai Gordhanbhai Vaghasiya was appointed as Director on 30 Jul 2026. Pareshbhai Bhagvanbhai Parsana was appointed as Director on 30 Jul 2026. Sheetalben Rachit Shah was appointed as Director on 10 Apr 2026. Crop Life Science has 31 board changes on record in total.

